Article
Inflammatory phenotypes and clinical outcomes amongst patients with presumed and confirmed Pneumocystis jirovecii pneumonia without underlying human immunodeficiency virus infection.
Pathogens and disease - 30 Jan 2025
Koh Matthew Chung Yi, Lum Lionel Hon-Wai, Tambyah Paul Anantharajah, Ngiam Jinghao Nicholas
Abstract excerpt
Pneumocystis jirovecii pneumonia (PJP) has significant mortality, especially in immunocompromised hosts without underlying human immunodeficiency virus infection (HIV). Inflammatory phenotypes may influence clinical outcomes. This study examines the relationship between inflammation, as measured by C-reactive protein (CRP), and adverse outcomes in HIV-negative patients with PJP. A retrospective analysis was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
